China’s First National Medical Insurance Standard: £145bn Opportunity for UK Life Sciences

Insight from Excellence First Enterprise Consultancy (EFEC) Disclaimer: This article is for general information only and does not constitute professional, financial, or legal advice. Market projections are based on current data and subject to change.

Strategic momentum: Building UK–China bridges in life sciences through Wuhan

Disclaimer: This article reflects EFEC’s views and insights based on information available as of August 2025. While believed to be accurate, some data are estimates or projections and may change over time. It is provided for general information only and does not constitute professional, investment, or commercial advice.

Parents to Raise £100k in Memory of Beloved Son for Cambridge Children’s Hospital

Eleven-year-old Elliott-James Heslop, or Elliott as he was known to family and friends, passed away from a rare, incurable disease called TTC7A deficiency last year, having been diagnosed with it at three months old. TTC7A deficiency is a condition that causes diarrhoea, inflammation of the intestines, bowel obstructions, immune dysfunction, and an inability to absorb nutrients. Now, his…

Team Consulting and inclusive surgical devices at Royal College of Surgeons of England event

Team Consulting are attending the Women at the Cutting Edge event hosted by the Royal College of Surgeons of England, in partnership with the RCS England I-Hub and Women in Surgery (WinS) group, on Friday 17th October 2025 at the Birmingham Repertory Theatre. Team's Senior FEI Strategy and Innovation Consultant, Lara Zaki, and Senior Human Factors Consultant, Claire Young, will lead a workshop…

Camena Bioscience and Constructive Bio join synthetic biology collaboration to develop plant genomics

Project backed by £9.1m funding from ARIA, the Advanced Research + Invention Agency, to develop synthetic chloroplast genomesProject is led by the Max-Planck Institute of Molecular Plant Physiology and also includes academics from University of Essex a

Sunil Shah and Dr Catherine Elton join Atelerix’s Board to drive global commercial expansion

Industry leaders Sunil Shah (CEO, o2h Ventures) and Dr Catherine Elton (CBO, Axol Bioscience) appointed as Chair and Non-Executive Director, respectively

Clinical insights: Respiratory care digital innovation opportunities

Co-authored by Dr Bipin Patel, CEO, electronRx, Cambridge, UK and  Dr Hiromichi Yamaguchi, Yamaguchi Respiratory Clinic and Dermatology, Tokyo, Japan. 

Plan smarter, not harder: Time-saving campaign template for science marketers

Use Qincade's template to guide you in selecting the most effective channels for your campaigns and inform your content creation plan; covering product launches, lead gen campaigns for webinars (internal and external), lead gen from a content piece like a wh8itepaper, promotions and tradeshow promotion (before and after show tactics).

Insights from the UK Life Sciences Start-up Report 2025: Building bridges with China for mutual growth

Disclaimer: This article is for informational purposes only and reflects the author’s independent observations on the UK life sciences sector and international collaboration opportunities. It does not constitute investment advice.

First non-hormonal menopause treatment approved for use in the UK by the MHRA, with early-stage development at Stevenage Bioscience Catalyst

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved elinzanetant (branded as Lynkuet™) for the treatment of moderate to severe hot flushes and night sweats associated with menopause. These symptoms, also known as vasomotor symptoms, affect a significant proportion of women and can have a considerable impact on quality of life.Elinzanetant is the first non-hormonal…

Online Mental Health First Aid Training in September 2025

Promote Mental Health will be running an open Online Mental Health First Aid Training Course on: 9th, 10th, 16th and 17th September from 9am to 1pm. This is an accredited course by Mental Health First Aid England, and will qualify you as a Mental Health First Aider Contact me today to secure a place - Claire Harris, [email protected], 07360 602316

Guardtech elevating cleanroom design capabilities through collaboration, co-ordination and utilisation of elite digital tools

Guardtech Group Design Manager Jack Burrow explains how the Suffolk-based cleanroom construction experts are embracing new technology and methodologies to take their project provision to new heights

CPFT psychiatrist publishes book to guide person-centred care

Dr Robert Dudas, consultant old age psychiatrist at Cambridgeshire and Peterborough NHS Foundation Trust (CPFT), has edited and published a new book to support best practice for mental health care and recovery.

NPZ Technology and CCV to showcase cross-border innovation at Cambridge Tech Week 2025

As Innovation Zone Sponsors at Cambridge Tech Week 2025, NPZ Technology Ltd and Cambridge Collaborative Ventures Ltd (CCV) will host an exhibition zone in Innovation Alley, featuring five cross-border innovation companies in digital health, VR, robotics, and AI.

No more chaos: A clear, confident NPD launch guide for science marketers

Launching a new product can easily become overwhelming, but this article offers a step-by-step roadmap to keep you organised, aligned, and focused- plus a free template to ensure you don’t miss a beat. Perfect for science marketers who want to launch with confidence.

Construction partner appointed for new Cambridge Children’s Hospital

The Cambridge Children’s Hospital project has appointed Bouygues UK as its construction partner for a groundbreaking new hospital that will redefine how we care for children and young people.

Antibodies.com expands UK headquarters with new 5x larger facilities in Cambridge to accommodate rapid growth

Cambridge, UK, 04 August 2025: Antibodies.com, a trusted provider of high-quality biological reagents for life science researchers, today announced the expansion of its UK headquarters with a move to Cambridge Technopark to accommodate the Company’

UK perspective: Harnessing the power of global collaboration in Precision Oncology

Disclaimer:The views expressed in this article reflect the professional perspective and experience of Excellence First Enterprise Consultancy Ltd (EFEC). This content is intended for informational purposes only and does not constitute commercial endorsement, medical advice, or solicitation of investment. EFEC is committed to providing balanced, objective commentary and supports open,…

Cambridge Innovation Capital commits £100m to back University of Cambridge spinouts

New Entrepreneur in Residence programme matches serial entrepreneurs with academics to develop world-leading ideas and IP.

Revenue growth continues - H1 and Q2 2025 results

Pascal Soriot, Chief Executive Officer, AstraZeneca, commenting on the results said:“Our strong momentum in revenue growth continued through the first half of the year and the delivery from our broad and diverse pipeline has been excellent, with 12 positive key Phase III trial readouts including for baxdrostat, gefurulimab, and Tagrisso in just the past few weeks.

Preventing patient hospitalisation through better stratification and timely intervention

In the realm of healthcare, patient hospitalisation can often be avoided through timely intervention and appropriate medication management.

Centauri Therapeutics receives an additional $5.1M from CARB-X to progress ABX-01 lead compound to first in human clinical trials

CARB-X provides an additional $5.1M to complete the non-clinical safety and efficacy studies with ABX-01 lead candidateCentauri plans the progression of lead candidate, an immunotherapy based broad-spectrum antimicrobial, to a first in human clinical study in early 2026

Exonate plans ‘CLEAR-DE’ Phase IIb clinical trial of lead candidate EXN407 for diabetic eye disease

EXN407 is the first topical SRPK1 inhibitor to demonstrate safety and efficacy as a monotherapy for non-proliferative diabetic retinopathy (NPDR) and diabetic macular oedemaPhase IIb trial to investigate efficacy in NPDR patients to commence in Q1 2026

Unlock the power of lead nurturing for business growth

Nurturing leads and customers isn’t just about courtesy- it’s a powerful way to boost engagement, conversions, and long-term value for your business, with some companies seeing 30%+ conversion rates from nurtured leads turned into customers.

Navigating the UK life sciences talent landscape in 2025: Growth opportunities, key challenges and strategies for integrating Chinese expertise

Disclaimer: This article is intended for industry professionals and provides general educational information only. It does not promote specific products or constitute medical advice.Market OverviewThe UK life sciences sector remains a cornerstone of the national economy, employing around 300,000 people and contributing approximately £100 billion annually. In 2025, the market shows signs of…